Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections

Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections UsingIn VivoMicrodialysis

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid pharmacokinetics and pharmacodynamics in clinical treatment

(2011) M. S. Dryden   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

(2011) Goodarz Danaei et al.   LANCET

Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice

(2010) Raju Sunagar et al.   RESEARCH IN MICROBIOLOGY

Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055

(2009) Manmeet Sakshi Bedi et al.   WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY

Pathogenesis of Methicillin‐ResistantStaphylococcus aureusInfection

(2008) Rachel J. Gordon et al.   CLINICAL INFECTIOUS DISEASES

Defects in Innate Immunity Predispose C57BL/6J-Leprdb/Leprdb Mice to Infection by Staphylococcus aureus

(2008) S. Park et al.   INFECTION AND IMMUNITY

Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice

(2008) S. Chhibber et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

(2007) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES